FDA Approves AQVESME for Anemia in Thalassemia
AQVESME is the only FDA-approved medicine for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia Agios Pharmaceuticals, Inc. , a commercial-stage biopharmaceutical company focused on delivering innovative medicines...